NCT03306901 - Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

October 20, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2033

Conditions

Esophageal Cancer

Interventions

PROCEDURE

Esophagectomy

Ivor Lewis esophagectomy or McKeown esophagectomy and systematic lymphadenectomy

DRUG

5-fluorouracil

3,200 \~ 4,000mg/m2 intravenously for 4 to 5 days.

DRUG

Cisplatin

45\~60mg intravenously over 1 hour on day 1

RADIATION

Radiation therapy

45 Gy irradiation (5 days a week for 5 weeks)

Trial Locations (9)

National Cancer Center, Goyang-si

Seoul National University Bundang Hospital, Seongnam

Asan Medical Center, Seoul

Gangnam Severance Hospital, Seoul

Korea University Guro Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Seoul St. Mary's Hospital, Seoul

Pusan National University Hospital, Pusan

All Listed Sponsors

collaborator

Ministry of Health & Welfare, Korea

OTHER_GOV

lead

Samsung Medical Center

OTHER